Systems analysis of innate and adaptive immunity in Long COVID DOI
Michael J. Peluso, Mohamed Abdel‐Mohsen, Timothy J. Henrich

et al.

Seminars in Immunology, Journal Year: 2024, Volume and Issue: 72, P. 101873 - 101873

Published: March 1, 2024

Language: Английский

The neurobiology of long COVID DOI Creative Commons
Michelle Monje, Akiko Iwasaki

Neuron, Journal Year: 2022, Volume and Issue: 110(21), P. 3484 - 3496

Published: Oct. 7, 2022

Persistent neurological and neuropsychiatric symptoms affect a substantial fraction of people after COVID-19 represent major component the post-acute syndrome, also known as long COVID. Here, we review what is understood about pathobiology impact on CNS discuss possible neurobiological underpinnings cognitive affecting survivors. We propose chief mechanisms that may contribute to this emerging health crisis.

Language: Английский

Citations

297

The immunology of long COVID DOI Open Access
Daniel M. Altmann, Emily M. Whettlock, Siyi Liu

et al.

Nature reviews. Immunology, Journal Year: 2023, Volume and Issue: 23(10), P. 618 - 634

Published: July 11, 2023

Language: Английский

Citations

261

Biomarkers in long COVID-19: A systematic review DOI Creative Commons
Yun‐Ju Lai, Shou-Hou Liu,

Sumatchara Manachevakul

et al.

Frontiers in Medicine, Journal Year: 2023, Volume and Issue: 10

Published: Jan. 20, 2023

Purpose Long COVID, also known as post-acute sequelae of COVID-19, refers to the constellation long-term symptoms experienced by people suffering persistent for one or more months after SARS-CoV-2 infection. Blood biomarkers can be altered in long COVID patients; however, associated with and their roles disease progression remain undetermined. This study aims systematically evaluate blood that may act indicators therapeutic targets COVID. Methods A systematic literature review PubMed, Embase, CINAHL was performed on 18 August 2022. The search keywords COVID-19 were used filter out eligible studies, which then carefully evaluated. Results Identified from 28 studies representing six biological classifications, 113 significantly COVID: (1) Cytokine/Chemokine (38, 33.6%); (2) Biochemical markers (24, 21.2%); (3) Vascular (20, 17.7%); (4) Neurological (6, 5.3%); (5) Acute phase protein (5, 4.4%); (6) Others 17.7%). Compared healthy control recovered patients without symptoms, 79 increased, 29 decreased, 5 required further determination patients. Of these, up-regulated Interleukin 6, C-reactive protein, tumor necrosis factor alpha might serve potential diagnostic Moreover, neurological exhibited higher levels neurofilament light chain glial fibrillary acidic whereas those pulmonary a level transforming growth beta. Conclusion present elevated inflammatory initial Our found significant associations between specific symptoms. Further investigations are warranted identify core set diagnose manage clinical practice.

Language: Английский

Citations

146

Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation DOI Open Access
Sally Singh, Molly M Baldwin, Enya Daynes

et al.

The Lancet Respiratory Medicine, Journal Year: 2023, Volume and Issue: 11(8), P. 709 - 725

Published: May 19, 2023

Language: Английский

Citations

95

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization DOI Creative Commons
Maxime Taquet,

Zuzanna Skórniewska,

Adam Hampshire

et al.

Nature Medicine, Journal Year: 2023, Volume and Issue: 29(10), P. 2498 - 2508

Published: Aug. 31, 2023

Post-COVID cognitive deficits, including 'brain fog', are clinically complex, with both objective and subjective components. They common debilitating, can affect the ability to work, yet their biological underpinnings remain unknown. In this prospective cohort study of 1,837 adults hospitalized COVID-19, we identified two distinct biomarker profiles measured during acute admission, which predict outcomes 6 12 months after COVID-19. A first profile links elevated fibrinogen relative C-reactive protein deficits. second D-dimer deficits occupational impact. This was mediated by fatigue shortness breath. Neither significantly depression or anxiety. Results were robust across secondary analyses. replicated, specificity COVID-19 tested, in a large-scale electronic health records dataset. These findings provide insights into heterogeneous biology post-COVID

Language: Английский

Citations

65

COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction DOI Open Access
Ekaterina Georgieva, Julian Ananiev,

Y. Yovchev

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(19), P. 14876 - 14876

Published: Oct. 4, 2023

SARS-CoV-2 infection, discovered and isolated in Wuhan City, Hubei Province, China, causes acute atypical respiratory symptoms has led to profound changes our lives. COVID-19 is characterized by a wide range of complications, which include pulmonary embolism, thromboembolism arterial clot formation, arrhythmias, cardiomyopathy, multiorgan failure, more. The disease caused worldwide pandemic, despite various measures such as social distancing, preventive strategies, therapeutic approaches, the creation vaccines, novel coronavirus infection (COVID-19) still hides many mysteries for scientific community. Oxidative stress been suggested play an essential role pathogenesis COVID-19, determining free radical levels patients with may provide insight into severity. generation abnormal oxidants under COVID-19-induced cytokine storm irreversible oxidation macromolecules subsequent damage cells, tissues, organs. Clinical studies have shown that oxidative initiates endothelial damage, increases risk complications post-COVID-19 or long-COVID-19 cases. This review describes radicals mediation mitochondrial dysfunction.

Language: Английский

Citations

64

Thromboinflammation in long COVID—the elusive key to postinfection sequelae? DOI Creative Commons
Leo Nicolai, Rainer Kaiser, Konstantin Stark

et al.

Journal of Thrombosis and Haemostasis, Journal Year: 2023, Volume and Issue: 21(8), P. 2020 - 2031

Published: May 11, 2023

Language: Английский

Citations

51

Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19 DOI Creative Commons
Gregg W. Stone, Michael E. Farkouh, Anuradha Lala

et al.

Journal of the American College of Cardiology, Journal Year: 2023, Volume and Issue: 81(18), P. 1747 - 1762

Published: March 6, 2023

Language: Английский

Citations

50

Fibrin drives thromboinflammation and neuropathology in COVID-19 DOI Creative Commons
Jae Kyu Ryu, Zhaoqi Yan, Mauricio Montaño

et al.

Nature, Journal Year: 2024, Volume and Issue: 633(8031), P. 905 - 913

Published: Aug. 28, 2024

Abstract Life-threatening thrombotic events and neurological symptoms are prevalent in COVID-19 persistent patients with long COVID experiencing post-acute sequelae of SARS-CoV-2 infection 1–4 . Despite the clinical evidence 1,5–7 , underlying mechanisms coagulopathy its consequences inflammation neuropathology remain poorly understood treatment options insufficient. Fibrinogen, central structural component blood clots, is abundantly deposited lungs brains COVID-19, correlates disease severity a predictive biomarker for post-COVID-19 cognitive deficits 1,5,8–10 Here we show that fibrin binds to spike protein, forming proinflammatory clots drive systemic thromboinflammation COVID-19. Fibrin, acting through inflammatory domain, required oxidative stress macrophage activation lungs, whereas it suppresses natural killer cells, after infection. Fibrin promotes neuroinflammation neuronal loss infection, as well innate immune brain independently active A monoclonal antibody targeting domain provides protection from microglial injury, lung Thus, drives fibrin-targeting immunotherapy may represent therapeutic intervention acute COVID.

Language: Английский

Citations

26

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches DOI Creative Commons
Roxana Gheorghiţă, Iuliana Șoldănescu, Andrei Lobiuc

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: March 4, 2024

The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has been defined as the greatest global health and socioeconomic crisis of modern times. While most people recover after being infected with virus, a significant proportion them continue to experience issues weeks, months even years acute infection SARS-CoV-2. This persistence clinical symptoms in individuals for at least three onset or emergence new lasting more than two months, without any other explanation alternative diagnosis have named long COVID, long-haul post-COVID-19 conditions, chronic post-acute sequelae (PASC). Long COVID characterized constellation disorders that vary widely their manifestations. Further, mechanisms underlying are not fully understood, which hamper efficient treatment options. review describes predictors common related COVID's effects on central peripheral nervous system organs tissues. Furthermore, transcriptional markers, molecular signaling pathways risk factors such sex, age, pre-existing condition, hospitalization during phase COVID-19, vaccination, lifestyle presented. Finally, recommendations patient rehabilitation management, well therapeutical approaches discussed. Understanding complexity this disease, its across multiple organ systems overlapping pathologies possible paramount developing diagnostic tools treatments.

Language: Английский

Citations

23